NRXS vs. VANI, STIM, ICCM, APT, CTSO, WOK, APYX, DHAI, TMDIF, and ICAD
Should you be buying NeurAxis stock or one of its competitors? The main competitors of NeurAxis include Vivani Medical (VANI), Neuronetics (STIM), IceCure Medical (ICCM), Alpha Pro Tech (APT), Cytosorbents (CTSO), WORK Medical Technology Group LTD Ordinary Shares (WOK), Apyx Medical (APYX), DIH Holding US (DHAI), Titan Medical (TMDIF), and iCAD (ICAD). These companies are all part of the "medical equipment" industry.
NeurAxis vs.
Vivani Medical (NASDAQ:VANI) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, community ranking, risk, valuation, profitability, institutional ownership and earnings.
In the previous week, NeurAxis had 1 more articles in the media than Vivani Medical. MarketBeat recorded 2 mentions for NeurAxis and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.93 beat NeurAxis' score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.
Vivani Medical currently has a consensus target price of $3.00, suggesting a potential upside of 150.00%. Given Vivani Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Vivani Medical is more favorable than NeurAxis.
Vivani Medical has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.2, meaning that its share price is 320% more volatile than the S&P 500.
Vivani Medical has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Vivani Medical's return on equity.
6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 44.3% of Vivani Medical shares are owned by insiders. Comparatively, 15.2% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
NeurAxis has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than NeurAxis, indicating that it is currently the more affordable of the two stocks.
Vivani Medical received 1 more outperform votes than NeurAxis when rated by MarketBeat users.
Summary
Vivani Medical beats NeurAxis on 9 of the 16 factors compared between the two stocks.
Get NeurAxis News Delivered to You Automatically
Sign up to receive the latest news and ratings for NRXS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeurAxis Competitors List
Related Companies and Tools
This page (NASDAQ:NRXS) was last updated on 1/22/2025 by MarketBeat.com Staff
Free NRXS Stock Alerts